{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:05:03Z","timestamp":1780459503737,"version":"3.54.1"},"reference-count":97,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sciences"],"abstract":"<jats:p>Gliomas remain among the most treatment-resistant malignancies of the central nervous system. Glioblastoma (GBM), the most aggressive adult-type diffuse glioma, is associated with persistently poor survival despite maximal safe resection followed by chemoradiation. Gliomas do not grow in isolation. Work over the past twenty years has dismantled the older tumor-centric view of glioma biology, replacing it with a model in which malignant cells operate within a tumor microenvironment (TME) composed of immune, vascular, stromal, and neural elements that together govern disease behavior. What makes the glioma TME so difficult to treat is not just its composition of immune cells, vasculature, stroma, and neurons, but the fact that these elements are arranged unevenly across the tumor. Different regions harbor different cellular mixtures and signaling environments, and, as a result, different vulnerabilities to therapy. Cytoreduction has not lost its importance, far from it. However, the same surgical window now also serves a different purpose; it lets the surgeon see which tissue is biologically dangerous rather than just visually abnormal, locate the true edge of infiltration, and get therapeutics past a blood\u2013brain barrier (BBB) that has historically locked them out of the brain. This review examines two technology domains, including: (1) optical theranostics (5-aminolevulinic acid fluorescence-guided surgery, fluorescein-guided visualization, Raman spectroscopy, and stimulated Raman histology); and (2) blood\u2013brain barrier disrupting technologies. The direction they collectively point toward is a version of glioma surgery that is guided less by anatomy and more by the biology of the tumor itself.<\/jats:p>","DOI":"10.3390\/brainsci16060578","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:37:26Z","timestamp":1780454246000},"page":"578","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tunable Technologies for the Glioma Tumor Microenvironment: A Comprehensive Review on Bench-to-Bedside Neurosurgical Advances"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1058-2137","authenticated-orcid":false,"given":"Eshita","family":"Sharma","sequence":"first","affiliation":[{"name":"David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julieta","family":"Serobyan","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4573-8234","authenticated-orcid":false,"given":"Numa","family":"Rajab","sequence":"additional","affiliation":[{"name":"Department of Medicine, Sulaiman Al Rajhi University, Al Bukayriyah 52726, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4467-611X","authenticated-orcid":false,"given":"Aisha Rizwan","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jinnah Medical and Dental College, Karachi 74800, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Guru","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, University of Cambridge, Cambridge CB2 1TN, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K.","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"iii1","DOI":"10.1093\/neuonc\/noab200","article-title":"CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2014\u20132018","volume":"23","author":"Ostrom","year":"2021","journal-title":"Neuro-Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/S0140-6736(23)01054-1","article-title":"Primary brain tumours in adults","volume":"402","author":"Bent","year":"2023","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","article-title":"The microenvironmental landscape of brain tumors","volume":"31","author":"Quail","year":"2017","journal-title":"Cancer Cell"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/glia.21136","article-title":"The brain tumor microenvironment","volume":"59","author":"Charles","year":"2011","journal-title":"Glia"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.trecan.2015.10.009","article-title":"Glioblastoma: Defining tumor niches","volume":"1","author":"Hambardzumyan","year":"2015","journal-title":"Trends Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1146\/annurev-pathmechdis-042524-025950","article-title":"Immunopathology of glioblastoma","volume":"20","author":"Li","year":"2026","journal-title":"Annu. Rev. Pathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nn.4185","article-title":"The role of microglia and macrophages in glioma maintenance and progression","volume":"19","author":"Hambardzumyan","year":"2016","journal-title":"Nat. Neurosci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nature20123","article-title":"Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma","volume":"539","author":"Tirosh","year":"2016","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41593-020-00789-y","article-title":"Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization","volume":"24","author":"Antunes","year":"2021","journal-title":"Nat. Neurosci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1158\/1078-0432.CCR-17-1846","article-title":"T-cell exhaustion signatures vary with tumor type and are severe in glioblastoma","volume":"24","author":"Woroniecka","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.celrep.2016.10.052","article-title":"Macrophage ontogeny underlies differences in tumor-specific education in brain malignancies","volume":"17","author":"Bowman","year":"2016","journal-title":"Cell Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/nm.3337","article-title":"CSF-1R inhibition alters macrophage polarization and blocks glioma progression","volume":"19","author":"Pyonteck","year":"2013","journal-title":"Nat. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41571-018-0003-5","article-title":"Current state of immunotherapy for glioblastoma","volume":"15","author":"Lim","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e103790","DOI":"10.15252\/embj.2019103790","article-title":"Microglia promote glioblastoma via mTOR-mediated immunosuppression of the tumour microenvironment","volume":"39","author":"Dumas","year":"2020","journal-title":"EMBO J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.immuni.2024.04.006","article-title":"Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma","volume":"57","author":"Ugolini","year":"2024","journal-title":"Immunity"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1158\/0008-5472.CAN-10-2238","article-title":"Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemia","volume":"71","author":"Chao","year":"2011","journal-title":"Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1073\/pnas.1721434116","article-title":"Microglia are effector cells of CD47-SIRP\u03b1 antiphagocytic axis disruption against glioblastoma","volume":"116","author":"Hutter","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","article-title":"CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy","volume":"572","author":"Barkal","year":"2019","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Huang, S., Zhang, X., Wei, Y., and Xiao, Y. (2024). Checkpoint CD24 function on tumor and immunotherapy. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1367959"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrn2175","article-title":"Angiogenesis in brain tumours","volume":"8","author":"Jain","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.ajpath.2012.06.030","article-title":"Mechanisms of glioma-associated neovascularization","volume":"181","author":"Hardee","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00401-012-1066-5","article-title":"Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited","volume":"124","author":"Plate","year":"2012","journal-title":"Acta Neuropathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/neuonc\/nox175","article-title":"Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data","volume":"20","author":"Sarkaria","year":"2018","journal-title":"Neuro-Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/nature09557","article-title":"Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells","volume":"468","author":"Pallini","year":"2010","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41467-018-03050-0","article-title":"Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2\u03b1","volume":"9","author":"Wang","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood-brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41568-019-0205-x","article-title":"The blood-brain barrier and blood-tumour barrier in brain tumours and metastases","volume":"20","author":"Arvanitis","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1215\/S1152851704001115","article-title":"Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis","volume":"7","author":"Kaur","year":"2005","journal-title":"Neuro-Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1126\/science.aaf4405","article-title":"Hypoxic control of metastasis","volume":"352","author":"Rankin","year":"2016","journal-title":"Science"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ccr.2009.03.018","article-title":"Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells","volume":"15","author":"Li","year":"2009","journal-title":"Cancer Cell"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"218216","DOI":"10.1016\/j.canlet.2025.218216","article-title":"Tumor microenvironment in glioblastoma: The central role of the hypoxic-necrotic core","volume":"639","author":"Bayona","year":"2026","journal-title":"Cancer Lett."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ccell.2022.05.009","article-title":"Spatially resolved multi-omics deciphers bidirectional tumour-host interdependence in glioblastoma","volume":"40","author":"Ravi","year":"2022","journal-title":"Cancer Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s40478-024-01769-0","article-title":"Spatial transcriptomics reveals segregation of tumor cell states in glioblastoma and marked immunosuppression within the perinecrotic niche","volume":"12","author":"Liu","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/s41467-023-36707-6","article-title":"Spatial transcriptomics reveals niche-specific enrichment and vulnerabilities of radial glial stem-like cells in malignant gliomas","volume":"14","author":"Ren","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ccell.2025.11.006","article-title":"Multi-omic landscape of human gliomas from diagnosis to treatment and recurrence","volume":"44","author":"Piyadasa","year":"2026","journal-title":"Cancer Cell"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1038\/s41467-023-39933-0","article-title":"Spatial cellular architecture predicts prognosis in glioblastoma","volume":"14","author":"Zheng","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","article-title":"An integrative model of cellular states, plasticity, and genetics for glioblastoma","volume":"178","author":"Neftel","year":"2019","journal-title":"Cell"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1227\/01.neu.0000318159.21731.cf","article-title":"Glioma extent of resection and its impact on patient outcome","volume":"62","author":"Sanai","year":"2008","journal-title":"Neurosurgery"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.1016\/S1470-2045(24)00130-X","article-title":"The oncological role of resection in newly diagnosed diffuse adult-type glioma defined by the WHO 2021 classification: A review by the RANO Resect Group","volume":"25","author":"Karschnia","year":"2024","journal-title":"Lancet Oncol."},{"key":"ref_44","first-page":"e1","article-title":"Effect of extent of resection on survival of patients with glioblastoma, IDH-wild-type, WHO grade 4 (WHO 2021): Systematic review and meta-analysis","volume":"173","author":"Lee","year":"2023","journal-title":"World Neurosurg."},{"key":"ref_45","first-page":"999","article-title":"Extent of resection thresholds in molecular subgroups of newly diagnosed isocitrate dehydrogenase-wildtype glioblastoma","volume":"94","author":"Dono","year":"2024","journal-title":"Neurosurgery"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.3171\/2025.5.FOCUS25350","article-title":"The role of extent of resection, chemoradiation, and MGMT promoter methylation in overall survival in a large cohort of IDH-wildtype glioblastoma","volume":"59","author":"Parker","year":"2025","journal-title":"Neurosurg. Focus"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s11060-019-03109-y","article-title":"5-ALA fluorescence-guided surgery of CNS tumors","volume":"141","author":"Hadjipanayis","year":"2019","journal-title":"J. Neuro-Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S1470-2045(06)70665-9","article-title":"Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: A randomised controlled multicentre phase III trial","volume":"7","author":"Stummer","year":"2006","journal-title":"Lancet Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3171\/2014.12.JNS14391","article-title":"Quantitative fluorescence using 5-aminolevulinic acid-induced protoporphyrin IX biomarker as a surgical adjunct in low-grade glioma surgery","volume":"123","author":"Jacobs","year":"2015","journal-title":"J. Neurosurg."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Widhalm, G., Kiesel, B., Woehrer, A., Traub-Weidinger, T., Preusser, M., Marosi, C., Prayer, D., Hainfellner, J.A., Knosp, E., and Wolfsberger, S. (2013). 5-aminolevulinic acid induced fluorescence is a powerful intraoperative marker for precise histopathological grading of gliomas with non-significant contrast-enhancement. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0076988"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3171\/2010.2.JNS091322","article-title":"Coregistered fluorescence-enhanced tumor resection of malignant glioma: Relationships between \u03b4-aminolevulinic acid\u2013induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters","volume":"114","author":"Roberts","year":"2011","journal-title":"J. Neurosurg."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/bjc.2011.12","article-title":"Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy","volume":"104","author":"Teng","year":"2011","journal-title":"Br. J. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.3171\/2013.11.FOCUS13463","article-title":"Tumor detection with 5-aminolevulinic acid fluorescence and Gd-DTPA\u2013enhanced intraoperative MRI at the border of contrast-enhancing lesions: A prospective study based on histopathological assessment","volume":"36","author":"Coburger","year":"2014","journal-title":"Neurosurg. Focus"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1158\/1078-0432.CCR-17-1184","article-title":"Fluorescein-guided surgery for resection of high-grade gliomas: A multicentric prospective phase II study (FLUOGLIO)","volume":"24","author":"Acerbi","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"R370","DOI":"10.1088\/0031-9155\/61\/23\/R370","article-title":"A review of Raman spectroscopy advances with an emphasis on clinical translation challenges in oncology","volume":"61","author":"Jermyn","year":"2016","journal-title":"Phys. Med. Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41591-019-0715-9","article-title":"Near real-time intraoperative brain tumor diagnosis using stimulated Raman histology and deep neural networks","volume":"26","author":"Hollon","year":"2020","journal-title":"Nat. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1158\/1078-0432.CCR-23-3842","article-title":"Streamlined intraoperative brain tumor classification and molecular subtyping in stereotactic biopsies using stimulated Raman histology and deep learning","volume":"30","author":"Reinecke","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"0027","DOI":"10.1038\/s41551-016-0027","article-title":"Rapid intraoperative histology of unprocessed surgical specimens via fibre-laser-based stimulated Raman scattering microscopy","volume":"1","author":"Orringer","year":"2017","journal-title":"Nat. Biomed. Eng."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Rodriguez, B., Brown, C.S., Colan, J.A., Zhang, J.Y., Huq, S., Rivera, D., Young, T., Williams, T., Subramaniam, V., and Hadjipanayis, C. (2025). Fluorescence-guided surgery for gliomas: Past, present, and future. Cancers, 17.","DOI":"10.3390\/cancers17111837"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Nguyen, T.T.T., Mnatsakanyan, H., Yi, E., and Badr, C.E. (2025). Current and emerging fluorescence-guided techniques in glioma to enhance resection. Cancers, 17.","DOI":"10.3390\/cancers17162702"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Elliot, M., S\u00e9gaud, S., Lavrador, J.P., Vergani, F., Bhangoo, R., Ashkan, K., Xie, Y., Stasiuk, G.J., Vercauteren, T., and Shapey, J. (2025). Fluorescence guidance in glioma surgery: Current evidence and the drive toward objective margin differentiation. Cancers, 17.","DOI":"10.3390\/cancers17122019"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.3171\/2013.11.FOCUS13487","article-title":"Is fluorescein-guided technique able to help in resection of high-grade gliomas?","volume":"36","author":"Acerbi","year":"2014","journal-title":"Neurosurg. Focus"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3171\/2016.7.JNS16232","article-title":"Aggressive resection at the infiltrative margins of glioblastoma facilitated by intraoperative fluorescein guidance","volume":"127","author":"Neira","year":"2016","journal-title":"J. Neurosurg."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3171\/2020.5.JNS20376","article-title":"Raman spectroscopy to differentiate between fresh tissue samples of glioma and normal brain: A comparison with 5-ALA\u2013induced fluorescence-guided surgery","volume":"135","author":"Livermore","year":"2020","journal-title":"J. Neurosurg."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"100219","DOI":"10.1016\/j.modpat.2023.100219","article-title":"Clinical validation of stimulated Raman histology for rapid intraoperative diagnosis of central nervous system tumors","volume":"36","author":"Fang","year":"2023","journal-title":"Mod. Pathol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11060-021-03901-9","article-title":"Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: A systematic review","volume":"156","author":"Eatz","year":"2022","journal-title":"J. Neuro-Oncol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Gandhi, S., Meybodi, A.T., Belykh, E., Cavallo, C., Zhao, X., Syed, M.P., Moreira, L.B., Lawton, M.T., Nakaji, P., and Preul, M.C. (2019). Survival outcomes among patients with high-grade glioma treated with 5-aminolevulinic acid-guided surgery: A systematic review and meta-analysis. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.00620"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1227\/NEU.0000000000000929","article-title":"What is the surgical benefit of utilizing 5-aminolevulinic acid for fluorescence-guided surgery of malignant gliomas?","volume":"77","author":"Hadjipanayis","year":"2015","journal-title":"Neurosurgery"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11060-018-03061-3","article-title":"The impact of 5-aminolevulinic acid on extent of resection in newly diagnosed high-grade gliomas: A systematic review and single institutional experience","volume":"141","author":"Haider","year":"2019","journal-title":"J. Neurooncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3171\/2023.7.JNS231170","article-title":"Use of 5-ALA fluorescence\u2013guided surgery versus white-light conventional microsurgery for the resection of newly diagnosed glioblastomas (RESECT study): A French multicenter randomized phase III study","volume":"140","author":"Picart","year":"2023","journal-title":"J. Neurosurg."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.3171\/2021.5.JNS21310","article-title":"5-Aminolevulinic acid for enhanced surgical visualization of high-grade gliomas: A prospective, multicenter study","volume":"136","author":"Schupper","year":"2021","journal-title":"J. Neurosurg."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"914","DOI":"10.3171\/2018.10.JNS181174","article-title":"Utility of sodium fluorescein for achieving resection targets in glioblastoma: Increased gross-or near-total resections and prolonged survival","volume":"132","author":"Katsevman","year":"2019","journal-title":"J. Neurosurg."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1158\/1078-0432.CCR-18-3643","article-title":"Safety and feasibility of repeated and transient blood-brain barrier disruption by pulsed ultrasound in patients with recurrent glioblastoma","volume":"25","author":"Idbaih","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Sweeney, M.D., Zhao, Z., Montagne, A., Nelson, A.R., and Zlokovic, B.V. (2018). Blood-brain barrier: From physiology to disease and back. Physiol. Rev., 99.","DOI":"10.1152\/physrev.00050.2017"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41582-020-00418-z","article-title":"Applications of focused ultrasound in the brain: From thermoablation to drug delivery","volume":"17","author":"Meng","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1470-2045(23)00112-2","article-title":"Repeated blood-brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in recurrent glioblastoma: A phase 1 trial","volume":"24","author":"Sonabend","year":"2023","journal-title":"Lancet Oncol."},{"key":"ref_77","first-page":"108504","article-title":"Anticancer drug delivery by focused ultrasound-mediated blood-brain\/tumor barrier disruption for glioma therapy: From benchside to bedside","volume":"249","author":"Truillet","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41598-018-36340-0","article-title":"Blood-brain barrier opening in primary brain tumors with non-invasive MR-guided focused ultrasound: A clinical safety and feasibility study","volume":"9","author":"Mainprize","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e2103280118","DOI":"10.1073\/pnas.2103280118","article-title":"Localized blood-brain barrier opening in infiltrating gliomas with MRI-guided acoustic emissions-controlled focused ultrasound","volume":"118","author":"Anastasiadis","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/s41467-024-45818-7","article-title":"Repeated blood-brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: A phase I\/II clinical trial","volume":"15","author":"Carpentier","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/S1470-2045(25)00492-9","article-title":"Microbubble-enhanced transcranial focused ultrasound with temozolomide for patients with high-grade glioma (BT008NA): A multicentre, open-label, phase 1\/2 trial","volume":"26","author":"Woodworth","year":"2025","journal-title":"Lancet Oncol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1073\/pnas.91.6.2076","article-title":"Convection-enhanced delivery of macromolecules in the brain","volume":"91","author":"Bobo","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3171\/jns.1999.90.2.0315","article-title":"Variables affecting convection-enhanced delivery to the striatum: A systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time","volume":"90","author":"Chen","year":"1999","journal-title":"J. Neurosurg."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/neuonc\/nop054","article-title":"Phase III randomized trial of CED of IL13-PE38QQR compared with Gliadel wafers for recurrent glioblastoma","volume":"12","author":"Kunwar","year":"2010","journal-title":"Neuro-Oncol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3171\/2009.11.JNS091052","article-title":"Poor drug distribution as a possible explanation for the results of the PRECISE trial","volume":"113","author":"Sampson","year":"2010","journal-title":"J. Neurosurg."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11060-020-03408-9","article-title":"Convection-enhanced drug delivery for glioblastoma: A review","volume":"151","author":"Aghi","year":"2021","journal-title":"J. Neuro-Oncol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S1470-2045(22)00599-X","article-title":"Chronic convection-enhanced delivery of topotecan for patients with recurrent glioblastoma: A first-in-patient, single-centre, single-arm, phase 1b trial","volume":"23","author":"Spinazzi","year":"2022","journal-title":"Lancet Oncol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11060-024-04904-y","article-title":"A phase I study of convection-enhanced delivery of liposomal-irinotecan using real-time magnetic resonance imaging in patients with recurrent high-grade glioma","volume":"172","author":"Narsinh","year":"2025","journal-title":"J. Neuro-Oncol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1038\/s41467-025-57263-1","article-title":"Convection enhanced delivery of Rhenium (186Re) Obisbemeda (186RNL) in recurrent glioma: A multicenter, single arm, phase 1 clinical trial","volume":"16","author":"Brenner","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Rolfe, N.W., Dadario, N.B., Canoll, P., and Bruce, J.N. (2024). A review of therapeutic agents given by convection-enhanced delivery for adult glioblastoma. Pharmaceuticals, 17.","DOI":"10.3390\/ph17080973"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Rahman, M.A., Jalouli, M., Yadab, M.K., and Al-Zharani, M. (2025). Progress in drug delivery systems based on nanoparticles for improved glioblastoma therapy: Addressing challenges and investigating opportunities. Cancers, 17.","DOI":"10.3390\/cancers17040701"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"16125","DOI":"10.2147\/IJN.S563730","article-title":"Advances in PLGA-based drug delivery systems for glioblastoma treatment","volume":"20","author":"Roy","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"116113","DOI":"10.1016\/j.biopha.2023.116113","article-title":"Lipid-based nanoparticles to address the limitations of GBM therapy by overcoming the blood-brain barrier, targeting glioblastoma stem cells, and counteracting the immunosuppressive tumor microenvironment","volume":"171","author":"Zhao","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1080\/17435889.2025.2503694","article-title":"Recent advances in nanomaterial-based brain-targeted delivery systems for glioblastoma therapy","volume":"20","author":"Qu","year":"2025","journal-title":"Nanomedicine"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1038\/s41467-020-19225-7","article-title":"Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy","volume":"11","author":"Gregory","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jconrel.2017.11.026","article-title":"Dual-targeting immunoliposomes using angiopep-2 and CD133 antibody for glioblastoma stem cells","volume":"269","author":"Kim","year":"2018","journal-title":"J. Control. Release"}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/16\/6\/578\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T03:38:03Z","timestamp":1780457883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/16\/6\/578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":97,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["brainsci16060578"],"URL":"https:\/\/doi.org\/10.3390\/brainsci16060578","relation":{},"ISSN":["2076-3425"],"issn-type":[{"value":"2076-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]}}}